Lisanti Capital Growth, LLC
Source: SEC Form 13F · as of Mar 2026Lisanti Capital Growth, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $51.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$51.0M
| Company | Shares | Value |
|---|---|---|
| LGNDLigand Pharmaceuticals Incorporated | 38,612 | $7.7M |
| IONSIONIS PHARMACEUTICALS INC | 75,699 | $5.7M |
| PVLAPALVELLA THERAPEUTICS, INC. | 41,445 | $5.2M |
| KRYSKrystal Biotech, Inc. | 18,515 | $4.8M |
| APGEApogee Therapeutics, Inc. | 52,260 | $4.4M |
| AXSMAxsome Therapeutics, Inc. | 22,075 | $3.7M |
| MIRMMirum Pharmaceuticals, Inc. | 39,005 | $3.6M |
| HALOHALOZYME THERAPEUTICS, INC. | 54,445 | $3.5M |
| TARSTarsus Pharmaceuticals, Inc. | 41,815 | $2.9M |
| BBIOBridgeBio Pharma, Inc. | 31,405 | $2.3M |
| ALHCAlignment Healthcare Inc. | 130,280 | $2.3M |
| KNSAKiniksa Pharmaceuticals International, plc | 31,065 | $1.5M |
| TVTXTravere Therapeutics, Inc. | 48,185 | $1.4M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 12,410 | $1.0M |
| KALVKalVista Pharmaceuticals, Inc. | 43,775 | $881K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.